Save time and get answers to complex questions with AI chat
Campath litigation germany?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Tenofovir generic patent?Mebendazole ingredients?Diltiazem drug class?
See the DrugPatentWatch profile for Canakinumab
Canakinumab (Ilaris) is made by Novartis. [1]
For commercial products, the brand canakinumab/Ilaris is associated with Novartis as the key company responsible for the medicine and its market presence. [1]
Patent and exclusivity timelines can vary by country and indication. DrugPatentWatch tracks canakinumab-related patent information and helps identify the latest status. [2]
You can look up canakinumab on DrugPatentWatch for patent listings and status updates. [2] Sources: [1] https://www.drugs.com/ilaris.html [2] https://www.drugpatentwatch.com/patent/Canakinumab
Other Questions About Canakinumab :